The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A prospective randomized phase II trial evaluating maintenance GM-CSF in an intermittent chemotherapy (chemo) regimen for metastatic castration-resistant prostate cancer (mCRPC): A DoD prostate cancer clinical trials consortium trial.
Eric Jay Small
No relevant relationships to disclose
Vivian K. Weinberg
No relevant relationships to disclose
Charles J. Ryan
Honoraria - Sanofi
Celestia S. Higano
No relevant relationships to disclose
Amy Mimi Lin
No relevant relationships to disclose
Yvonne Maruca
No relevant relationships to disclose
Joshi J. Alumkal
No relevant relationships to disclose
Evan Y. Yu
No relevant relationships to disclose
Jonathan E. Rosenberg
No relevant relationships to disclose
Tomasz M. Beer
No relevant relationships to disclose